These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19212020)

  • 21. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design.
    Zeymer U; Arntz HR; Darius H; Huber K; Senges J
    Cardiology; 2007; 108(4):265-72. PubMed ID: 17114880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
    Gabriel RS; White HD
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early ST resolution after successful primary PCI is related to a favorable outcome in ST elevated AMI patients].
    Shen ZJ; Dai ST; Aliya T; Huang CL; Zhang SY; Zeng Y; Xie HZ; Fan ZJ; Liu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):134-7. PubMed ID: 16626580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes?
    Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
    Giraldez RR; Nicolau JC; Corbalan R; Gurfinkel EP; Juarez U; Lopez-Sendon J; Parkhomenko A; Molhoek P; Mohanavelu S; Morrow DA; Antman EM
    Eur Heart J; 2007 Jul; 28(13):1566-73. PubMed ID: 17562672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
    White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Steinhubl S; Montalescot G
    Am Heart J; 2009 Jan; 157(1):125-31. PubMed ID: 19081408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enoxaparin experience in percutaneous coronary intervention.
    Somani V; Trivedi S
    J Indian Med Assoc; 2008 Jan; 106(1):12-5. PubMed ID: 18705262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
    Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
    Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial).
    Dangas G; Stone GW; Weinberg MD; Webb J; Cox DA; Brodie BR; Krucoff MW; Gibbons RJ; Lansky AJ; Mehran R;
    Am Heart J; 2008 Jun; 155(6):1090-6. PubMed ID: 18513524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alteplase in acute coronary syndromes].
    Iturbe Orbe M; Jerjes-Sánchez Diaz C; García-Sosa A; García H; Reyes Cerezo E; Fernández D; Garza Ruiz A; Assad C; Castillo F; González M; García J; Valadéz F; Chávez M; Garza O
    Arch Cardiol Mex; 2008; 78(3):255-64. PubMed ID: 18959012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome.
    Lettieri C; Savonitto S; De Servi S; Guagliumi G; Belli G; Repetto A; Piccaluga E; Politi A; Ettori F; Castiglioni B; Fabbiocchi F; De Cesare N; Sangiorgi G; Musumeci G; Onofri M; D'Urbano M; Pirelli S; Zanini R; Klugmann S;
    Am Heart J; 2009 Mar; 157(3):569-575.e1. PubMed ID: 19249431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prehospital administration of enoxaparin before primary angioplasty for ST-elevation acute myocardial infarction.
    Labèque JN; Jaïs C; Dubos O; Denard M; Berhouet M; Leroux L; Laplace G; Vergnes C; Pradeau C; Thicoïpe M; Dos Santos P; Coste P
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):207-13. PubMed ID: 16416473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparison of early and late outcome of direct and conventional stenting of patients with st elevation myocardial infarction.
    Tacoy G; Yazici GE; Erden M; Timurkaynak T
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):181-6. PubMed ID: 19465441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI.
    De Vita M; Burzotta F; Trani C; Romagnoli E; Talarico GP; Porto I; Leone AM; Biondi-Zoccai GG; Niccoli G; Rebuzzi AG; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
    J Invasive Cardiol; 2008 Apr; 20(4):161-5. PubMed ID: 18398230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search for optimal combination of antiplatelet and anticoagulation regimens following PCI.
    Gruberg L; Beyar R
    J Invasive Cardiol; 2003 May; 15(5):240-1. PubMed ID: 12730629
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
    Witkowski A; Maciejewski P; Wasek W; Malek LA; Niewada M; Kaminski B; Drzewiecki J; Kosmider M; Kubica J; Ruzyllo W; Peruga JZ; Dudek D; Opolski G; Dobrzycki S; Gil RJ;
    Eur Heart J; 2009 Jul; 30(14):1736-43. PubMed ID: 19376786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.